Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Primary Care Organization

NCT ID: NCT05385666

Last Updated: 2022-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-13

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Frequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. The collaborative care model developed in Washington State with the introduction of a care manager is recognized. About 100 randomized controlled trials have established its effectiveness and efficiency, in terms of improving the progression of disorders (remission rate), adherence, quality of life, professional and patient satisfaction, and cost savings. However, the possibility of implementation of these validated care remains to be explored. A dozen collaborative care implementation studies exist, all conducted in the USA and not having considered all the dimensions of the indicators of penetration, acceptability/adoption, feasibility, fidelity and cost. A first implementation in France is implemented since September 2021 in the Yvelines department on four sites of different size, organization and environments: the multi-professional health centers (MSP) of Mureaux and Celle St Cloud, the Chevreuse medical house and MG in isolated practice in Versailles.

The main objective of the research project is to evaluate the first implementation in France of collaborative care for frequent psychic disorders according to the indicators of penetration, acceptability/adoption, fidelity, relevance, feasibility and cost.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychological Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group experimental

Group Type EXPERIMENTAL

collaborative cares

Intervention Type OTHER

coordinate care between city medicine and specialized psychiatric care to improve the management of common mental disorders

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

collaborative cares

coordinate care between city medicine and specialized psychiatric care to improve the management of common mental disorders

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthcare professionals involved in the collaborative care system
* patients who have been referred for collaborative care by their family physician

Exclusion Criteria

* patient refusal to participate in research
* adults protected by law
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr Nadia YOUNES

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Nadia YOUNES

Investigator Coordinator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maison de Santé Pluridisciplinaire

Chevreuse, , France

Site Status RECRUITING

Maison de Santé Pluridisciplinaire

Les Mureaux, , France

Site Status RECRUITING

Cabinet Médical Versailles

Versailles, , France

Site Status RECRUITING

cabinet médical Versailles

Versailles, , France

Site Status RECRUITING

Cabinet Médical Versailles

Versailles, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

nadia Younes

Role: CONTACT

01 39 63 83 12

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie Anne Duval-Cattaneo

Role: primary

marie Hélène certain

Role: primary

xavier gayraud

Role: primary

laurent de bastard

Role: primary

jerome barre

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P21/10_mosaïque

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Implementing FLOW
NCT04193033 COMPLETED NA